New

NVision Imaging Technologies

The AI engine Fit Assessment

Beta

The company will attend Deep Tech Momentum 2026

Blurb

NVision Imaging Technologies develops Quantum MRI agents for assessing early patient response to treatment at the metabolic level.

HQ Location

Ulm (Germany)

Founded

2015

Employees

51 - 200

Total funding raised

$100.24M

Funding Status

Grant, $1.53M, January 1, 2025

At NVision, we engineer quantum-powered medical imaging technologies that deliver deeper, more precise MRI data for researchers and clinicians.



Our unique hyperpolarization device POLARIS enables fast, simple, scalable imaging of metabolism at the cellular level. With hyperpolarized MRI, we are paving the way for earlier detection, faster treatment assessment and better risk profiling in oncology, cardiology, neurology and beyond.